APO RESEARCH · REPORT
Next-Generation Sequencing (NGS) Services
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
Product & engineering
Understand the product.
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
Selected research
Industry Research
Next-Generation Sequencing (NGS) Services Industry Research Report 2026
Market perspective
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Scope
This report quantifies the global Next-Generation Sequencing (NGS) Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Next-Generation Sequencing (NGS) Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Next-Generation Sequencing (NGS) Services Market by Company
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Next-Generation Sequencing (NGS) Services Segment by Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Next-Generation Sequencing (NGS) Services Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Next-Generation Sequencing (NGS) Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Next-Generation Sequencing (NGS) Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
Applications
- Hospitals and Clinics
- Biopharma Companies
- Academic & Research Organizations
- Others
Companies covered
- Eurofins Scientific
- Natera
- BGI
- Illumina
- Roche
- LabCorp
- Berry Genomics
- Brooks Life Sciences
- Macrogen
- Personalis
- Novogene
- Genotypic Technology
- Dna Link
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Next-Generation Sequencing (NGS) Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Targeted Sequencing
- 2.2.3 Whole Exome Sequencing
- 2.2.4 Whole Genome Sequencing
- 2.3 Next-Generation Sequencing (NGS) Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals and Clinics
- 2.3.3 Biopharma Companies
- 2.3.4 Academic & Research Organizations
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Next-Generation Sequencing (NGS) Services Breakdown Data by Type
- 3.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Type (2021-2026)
- 3.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Type (2027-2032)
4 Next-Generation Sequencing (NGS) Services Breakdown Data by Application
- 4.1 Global Next-Generation Sequencing (NGS) Services Historic Market Size by Application (2021-2026)
- 4.2 Global Next-Generation Sequencing (NGS) Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Next-Generation Sequencing (NGS) Services Market Perspective (2021-2032)
- 5.2 Global Next-Generation Sequencing (NGS) Services Growth Trends by Region
- 5.2.1 Global Next-Generation Sequencing (NGS) Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Next-Generation Sequencing (NGS) Services Historic Market Size by Region (2021-2026)
- 5.2.3 Next-Generation Sequencing (NGS) Services Forecasted Market Size by Region (2027-2032)
- 5.3 Next-Generation Sequencing (NGS) Services Market Dynamics
- 5.3.1 Next-Generation Sequencing (NGS) Services Industry Trends
- 5.3.2 Next-Generation Sequencing (NGS) Services Market Drivers
- 5.3.3 Next-Generation Sequencing (NGS) Services Market Challenges
- 5.3.4 Next-Generation Sequencing (NGS) Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue
- 6.1.1 Global Top Next-Generation Sequencing (NGS) Services Players by Revenue (2021-2026)
- 6.1.2 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Next-Generation Sequencing (NGS) Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Next-Generation Sequencing (NGS) Services Head Office and Area Served
- 6.4 Global Next-Generation Sequencing (NGS) Services Players, Product Type & Application
- 6.5 Global Next-Generation Sequencing (NGS) Services Manufacturers Established Date
- 6.6 Global Next-Generation Sequencing (NGS) Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
- 7.2 North America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2021-2026)
- 7.4 North America Next-Generation Sequencing (NGS) Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
- 8.2 Europe Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2021-2026)
- 8.4 Europe Next-Generation Sequencing (NGS) Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
- 9.2 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Next-Generation Sequencing (NGS) Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
- 10.2 South America Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Next-Generation Sequencing (NGS) Services Market Size by Country (2021-2026)
- 10.4 South America Next-Generation Sequencing (NGS) Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size (2021-2032)
- 11.2 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Next-Generation Sequencing (NGS) Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 Natera
- 12.2.1 Natera Company Information
- 12.2.2 Natera Business Overview
- 12.2.3 Natera Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.2.4 Natera Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.2.5 Natera Recent Developments
- 12.3 BGI
- 12.3.1 BGI Company Information
- 12.3.2 BGI Business Overview
- 12.3.3 BGI Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.3.4 BGI Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.3.5 BGI Recent Developments
- 12.4 Illumina
- 12.4.1 Illumina Company Information
- 12.4.2 Illumina Business Overview
- 12.4.3 Illumina Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.4.4 Illumina Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.4.5 Illumina Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.5.4 Roche Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 LabCorp
- 12.6.1 LabCorp Company Information
- 12.6.2 LabCorp Business Overview
- 12.6.3 LabCorp Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.6.4 LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.6.5 LabCorp Recent Developments
- 12.7 Berry Genomics
- 12.7.1 Berry Genomics Company Information
- 12.7.2 Berry Genomics Business Overview
- 12.7.3 Berry Genomics Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.7.5 Berry Genomics Recent Developments
- 12.8 Brooks Life Sciences
- 12.8.1 Brooks Life Sciences Company Information
- 12.8.2 Brooks Life Sciences Business Overview
- 12.8.3 Brooks Life Sciences Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.8.5 Brooks Life Sciences Recent Developments
- 12.9 Macrogen
- 12.9.1 Macrogen Company Information
- 12.9.2 Macrogen Business Overview
- 12.9.3 Macrogen Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.9.4 Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.9.5 Macrogen Recent Developments
- 12.10 Personalis
- 12.10.1 Personalis Company Information
- 12.10.2 Personalis Business Overview
- 12.10.3 Personalis Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.10.4 Personalis Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.10.5 Personalis Recent Developments
- 12.11 Novogene
- 12.11.1 Novogene Company Information
- 12.11.2 Novogene Business Overview
- 12.11.3 Novogene Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.11.4 Novogene Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.11.5 Novogene Recent Developments
- 12.12 Genotypic Technology
- 12.12.1 Genotypic Technology Company Information
- 12.12.2 Genotypic Technology Business Overview
- 12.12.3 Genotypic Technology Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.12.5 Genotypic Technology Recent Developments
- 12.13 Dna Link
- 12.13.1 Dna Link Company Information
- 12.13.2 Dna Link Business Overview
- 12.13.3 Dna Link Revenue in Next-Generation Sequencing (NGS) Services Business (2021-2026)
- 12.13.4 Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio
- 12.13.5 Dna Link Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst